0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Heart Lung Machines Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-24G2438
Home | Market Reports
Global Artificial Heart Lung Machines Market Insights Forecast to 2026
BUY CHAPTERS

Global Artificial Heart Lung Machines Market Research Report 2026

Code: QYRE-Auto-24G2438
Report
2026-02-05
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Heart Lung Machines Market Size

The global Artificial Heart Lung Machines market was valued at US$ 310 million in 2025 and is anticipated to reach US$ 404 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Artificial Heart Lung Machines Market

Artificial Heart Lung Machines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Artificial Heart Lung Machines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.
This report delivers a comprehensive overview of the global Artificial Heart Lung Machines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Heart Lung Machines. The Artificial Heart Lung Machines market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artificial Heart Lung Machines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Heart Lung Machines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Artificial Heart Lung Machines Market Report

Report Metric Details
Report Name Artificial Heart Lung Machines Market
Accounted market size in 2025 US$ 310 million
Forecasted market size in 2032 US$ 404 million
CAGR 3.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Single Roller Pump HLM
  • Double Roller Pump HLM
by Application
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Artificial Heart Lung Machines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Artificial Heart Lung Machines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Heart Lung Machines Market growing?

Ans: The Artificial Heart Lung Machines Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Artificial Heart Lung Machines Market size in 2032?

Ans: The Artificial Heart Lung Machines Market size in 2032 will be US$ 404 million.

What is the market share of major companies in Artificial Heart Lung Machines Market?

Ans: Global top five manufacturers hold a share about 95%.

What is the Artificial Heart Lung Machines Market share by region?

Ans: North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent.

What is the Artificial Heart Lung Machines Market share by type?

Ans: In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%.

Who are the main players in the Artificial Heart Lung Machines Market report?

Ans: The main players in the Artificial Heart Lung Machines Market are LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical

What are the Application segmentation covered in the Artificial Heart Lung Machines Market report?

Ans: The Applications covered in the Artificial Heart Lung Machines Market report are Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others

What are the Type segmentation covered in the Artificial Heart Lung Machines Market report?

Ans: The Types covered in the Artificial Heart Lung Machines Market report are Single Roller Pump HLM, Double Roller Pump HLM

1 Artificial Heart Lung Machines Market Overview
1.1 Product Definition
1.2 Artificial Heart Lung Machines by Type
1.2.1 Global Artificial Heart Lung Machines Market Value by Type: 2025 vs 2032
1.2.2 Single Roller Pump HLM
1.2.3 Double Roller Pump HLM
1.3 Artificial Heart Lung Machines by Application
1.3.1 Global Artificial Heart Lung Machines Market Value by Application: 2025 vs 2032
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Global Artificial Heart Lung Machines Market Size Estimates and Forecasts
1.4.1 Global Artificial Heart Lung Machines Revenue 2021–2032
1.4.2 Global Artificial Heart Lung Machines Sales 2021–2032
1.4.3 Global Artificial Heart Lung Machines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Artificial Heart Lung Machines Market Competition by Manufacturers
2.1 Global Artificial Heart Lung Machines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Artificial Heart Lung Machines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Artificial Heart Lung Machines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Artificial Heart Lung Machines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Artificial Heart Lung Machines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Artificial Heart Lung Machines, Product Types and Applications
2.7 Global Key Manufacturers of Artificial Heart Lung Machines, Date of Entry into the Industry
2.8 Global Artificial Heart Lung Machines Market Competitive Situation and Trends
2.8.1 Global Artificial Heart Lung Machines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Artificial Heart Lung Machines Players Market Share by Revenue
2.8.3 Global Artificial Heart Lung Machines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artificial Heart Lung Machines Market Scenario by Region
3.1 Global Artificial Heart Lung Machines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Artificial Heart Lung Machines Sales by Region: 2021–2032
3.2.1 Global Artificial Heart Lung Machines Sales by Region: 2021–2026
3.2.2 Global Artificial Heart Lung Machines Sales by Region: 2027–2032
3.3 Global Artificial Heart Lung Machines Revenue by Region: 2021–2032
3.3.1 Global Artificial Heart Lung Machines Revenue by Region: 2021–2026
3.3.2 Global Artificial Heart Lung Machines Revenue by Region: 2027–2032
3.4 North America Artificial Heart Lung Machines Market Facts & Figures by Country
3.4.1 North America Artificial Heart Lung Machines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Artificial Heart Lung Machines Sales by Country (2021–2032)
3.4.3 North America Artificial Heart Lung Machines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Heart Lung Machines Market Facts & Figures by Country
3.5.1 Europe Artificial Heart Lung Machines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Artificial Heart Lung Machines Sales by Country (2021–2032)
3.5.3 Europe Artificial Heart Lung Machines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Heart Lung Machines Market Facts & Figures by Region
3.6.1 Asia Pacific Artificial Heart Lung Machines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Artificial Heart Lung Machines Sales by Region (2021–2032)
3.6.3 Asia Pacific Artificial Heart Lung Machines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Heart Lung Machines Market Facts & Figures by Country
3.7.1 Latin America Artificial Heart Lung Machines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Artificial Heart Lung Machines Sales by Country (2021–2032)
3.7.3 Latin America Artificial Heart Lung Machines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Heart Lung Machines Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Heart Lung Machines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Artificial Heart Lung Machines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Artificial Heart Lung Machines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Heart Lung Machines Sales by Type (2021–2032)
4.1.1 Global Artificial Heart Lung Machines Sales by Type (2021–2026)
4.1.2 Global Artificial Heart Lung Machines Sales by Type (2027–2032)
4.1.3 Global Artificial Heart Lung Machines Sales Market Share by Type (2021–2032)
4.2 Global Artificial Heart Lung Machines Revenue by Type (2021–2032)
4.2.1 Global Artificial Heart Lung Machines Revenue by Type (2021–2026)
4.2.2 Global Artificial Heart Lung Machines Revenue by Type (2027–2032)
4.2.3 Global Artificial Heart Lung Machines Revenue Market Share by Type (2021–2032)
4.3 Global Artificial Heart Lung Machines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Artificial Heart Lung Machines Sales by Application (2021–2032)
5.1.1 Global Artificial Heart Lung Machines Sales by Application (2021–2026)
5.1.2 Global Artificial Heart Lung Machines Sales by Application (2027–2032)
5.1.3 Global Artificial Heart Lung Machines Sales Market Share by Application (2021–2032)
5.2 Global Artificial Heart Lung Machines Revenue by Application (2021–2032)
5.2.1 Global Artificial Heart Lung Machines Revenue by Application (2021–2026)
5.2.2 Global Artificial Heart Lung Machines Revenue by Application (2027–2032)
5.2.3 Global Artificial Heart Lung Machines Revenue Market Share by Application (2021–2032)
5.3 Global Artificial Heart Lung Machines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 LivaNova (Sorin)
6.1.1 LivaNova (Sorin) Company Information
6.1.2 LivaNova (Sorin) Description and Business Overview
6.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
6.1.5 LivaNova (Sorin) Recent Developments/Updates
6.2 Getinge (Maquet)
6.2.1 Getinge (Maquet) Company Information
6.2.2 Getinge (Maquet) Description and Business Overview
6.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
6.2.5 Getinge (Maquet) Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo CV Group
6.4.1 Terumo CV Group Company Information
6.4.2 Terumo CV Group Description and Business Overview
6.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
6.4.5 Terumo CV Group Recent Developments/Updates
6.5 Braile Biomedica
6.5.1 Braile Biomedica Company Information
6.5.2 Braile Biomedica Description and Business Overview
6.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
6.5.5 Braile Biomedica Recent Developments/Updates
6.6 Tianjin Medical
6.6.1 Tianjin Medical Company Information
6.6.2 Tianjin Medical Description and Business Overview
6.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
6.6.5 Tianjin Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Heart Lung Machines Industry Chain Analysis
7.2 Artificial Heart Lung Machines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Heart Lung Machines Production Mode & Process Analysis
7.4 Artificial Heart Lung Machines Sales and Marketing
7.4.1 Artificial Heart Lung Machines Sales Channels
7.4.2 Artificial Heart Lung Machines Distributors
7.5 Artificial Heart Lung Machines Customer Analysis
8 Artificial Heart Lung Machines Market Dynamics
8.1 Artificial Heart Lung Machines Industry Trends
8.2 Artificial Heart Lung Machines Market Drivers
8.3 Artificial Heart Lung Machines Market Challenges
8.4 Artificial Heart Lung Machines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Artificial Heart Lung Machines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Artificial Heart Lung Machines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Artificial Heart Lung Machines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Artificial Heart Lung Machines Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Artificial Heart Lung Machines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Artificial Heart Lung Machines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Artificial Heart Lung Machines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Artificial Heart Lung Machines Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Artificial Heart Lung Machines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Artificial Heart Lung Machines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Artificial Heart Lung Machines, Product Types and Applications
 Table 12. Global Key Manufacturers of Artificial Heart Lung Machines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Artificial Heart Lung Machines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Artificial Heart Lung Machines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artificial Heart Lung Machines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Artificial Heart Lung Machines Sales by Region (K Units), 2021–2026
 Table 18. Global Artificial Heart Lung Machines Sales Market Share by Region (2021–2026)
 Table 19. Global Artificial Heart Lung Machines Sales by Region (K Units), 2027–2032
 Table 20. Global Artificial Heart Lung Machines Sales Market Share by Region (2027–2032)
 Table 21. Global Artificial Heart Lung Machines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Artificial Heart Lung Machines Revenue Market Share by Region (2021–2026)
 Table 23. Global Artificial Heart Lung Machines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Artificial Heart Lung Machines Revenue Market Share by Region (2027–2032)
 Table 25. North America Artificial Heart Lung Machines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Artificial Heart Lung Machines Sales by Country (K Units), 2021–2026
 Table 27. North America Artificial Heart Lung Machines Sales by Country (K Units), 2027–2032
 Table 28. North America Artificial Heart Lung Machines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Artificial Heart Lung Machines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Artificial Heart Lung Machines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Artificial Heart Lung Machines Sales by Country (K Units), 2021–2026
 Table 32. Europe Artificial Heart Lung Machines Sales by Country (K Units), 2027–2032
 Table 33. Europe Artificial Heart Lung Machines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Artificial Heart Lung Machines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Artificial Heart Lung Machines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Artificial Heart Lung Machines Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Artificial Heart Lung Machines Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Artificial Heart Lung Machines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Artificial Heart Lung Machines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Artificial Heart Lung Machines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Artificial Heart Lung Machines Sales by Country (K Units), 2021–2026
 Table 42. Latin America Artificial Heart Lung Machines Sales by Country (K Units), 2027–2032
 Table 43. Latin America Artificial Heart Lung Machines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Artificial Heart Lung Machines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Artificial Heart Lung Machines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Artificial Heart Lung Machines Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Artificial Heart Lung Machines Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Artificial Heart Lung Machines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Artificial Heart Lung Machines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Artificial Heart Lung Machines Sales (K Units) by Type (2021–2026)
 Table 51. Global Artificial Heart Lung Machines Sales (K Units) by Type (2027–2032)
 Table 52. Global Artificial Heart Lung Machines Sales Market Share by Type (2021–2026)
 Table 53. Global Artificial Heart Lung Machines Sales Market Share by Type (2027–2032)
 Table 54. Global Artificial Heart Lung Machines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Artificial Heart Lung Machines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021–2026)
 Table 57. Global Artificial Heart Lung Machines Revenue Market Share by Type (2027–2032)
 Table 58. Global Artificial Heart Lung Machines Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Artificial Heart Lung Machines Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Artificial Heart Lung Machines Sales (K Units) by Application (2021–2026)
 Table 61. Global Artificial Heart Lung Machines Sales (K Units) by Application (2027–2032)
 Table 62. Global Artificial Heart Lung Machines Sales Market Share by Application (2021–2026)
 Table 63. Global Artificial Heart Lung Machines Sales Market Share by Application (2027–2032)
 Table 64. Global Artificial Heart Lung Machines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Artificial Heart Lung Machines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021–2026)
 Table 67. Global Artificial Heart Lung Machines Revenue Market Share by Application (2027–2032)
 Table 68. Global Artificial Heart Lung Machines Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Artificial Heart Lung Machines Price (USD/Unit) by Application (2027–2032)
 Table 70. LivaNova (Sorin) Company Information
 Table 71. LivaNova (Sorin) Description and Business Overview
 Table 72. LivaNova (Sorin) Artificial Heart Lung Machines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. LivaNova (Sorin) Artificial Heart Lung Machines Product
 Table 74. LivaNova (Sorin) Recent Developments/Updates
 Table 75. Getinge (Maquet) Company Information
 Table 76. Getinge (Maquet) Description and Business Overview
 Table 77. Getinge (Maquet) Artificial Heart Lung Machines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Getinge (Maquet) Artificial Heart Lung Machines Product
 Table 79. Getinge (Maquet) Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Artificial Heart Lung Machines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Medtronic Artificial Heart Lung Machines Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Terumo CV Group Company Information
 Table 86. Terumo CV Group Description and Business Overview
 Table 87. Terumo CV Group Artificial Heart Lung Machines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Terumo CV Group Artificial Heart Lung Machines Product
 Table 89. Terumo CV Group Recent Developments/Updates
 Table 90. Braile Biomedica Company Information
 Table 91. Braile Biomedica Description and Business Overview
 Table 92. Braile Biomedica Artificial Heart Lung Machines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Braile Biomedica Artificial Heart Lung Machines Product
 Table 94. Braile Biomedica Recent Developments/Updates
 Table 95. Tianjin Medical Company Information
 Table 96. Tianjin Medical Description and Business Overview
 Table 97. Tianjin Medical Artificial Heart Lung Machines Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Tianjin Medical Artificial Heart Lung Machines Product
 Table 99. Tianjin Medical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Artificial Heart Lung Machines Distributors List
 Table 103. Artificial Heart Lung Machines Customers List
 Table 104. Artificial Heart Lung Machines Market Trends
 Table 105. Artificial Heart Lung Machines Market Drivers
 Table 106. Artificial Heart Lung Machines Market Challenges
 Table 107. Artificial Heart Lung Machines Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artificial Heart Lung Machines
 Figure 2. Global Artificial Heart Lung Machines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Artificial Heart Lung Machines Market Share by Type: 2025 & 2032
 Figure 4. Single Roller Pump HLM Product Picture
 Figure 5. Double Roller Pump HLM Product Picture
 Figure 6. Global Artificial Heart Lung Machines Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Artificial Heart Lung Machines Market Share by Application: 2025 & 2032
 Figure 8. Cardiac Surgery
 Figure 9. Lung Transplant Operation
 Figure 10. Acute Respiratory Failure Treatment
 Figure 11. Others
 Figure 12. Global Artificial Heart Lung Machines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Artificial Heart Lung Machines Market Size (US$ Million), 2021–2032
 Figure 14. Global Artificial Heart Lung Machines Sales (K Units), 2021–2032
 Figure 15. Global Artificial Heart Lung Machines Average Price (USD/Unit), 2021–2032
 Figure 16. Artificial Heart Lung Machines Report Years Considered
 Figure 17. Artificial Heart Lung Machines Sales Share by Manufacturers in 2025
 Figure 18. Global Artificial Heart Lung Machines Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Artificial Heart Lung Machines Players: Market Share by Revenue in Artificial Heart Lung Machines in 2025
 Figure 20. Artificial Heart Lung Machines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Artificial Heart Lung Machines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Artificial Heart Lung Machines Sales Market Share by Country (2021–2032)
 Figure 23. North America Artificial Heart Lung Machines Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Artificial Heart Lung Machines Sales Market Share by Country (2021–2032)
 Figure 27. Europe Artificial Heart Lung Machines Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Artificial Heart Lung Machines Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Artificial Heart Lung Machines Revenue Market Share by Region (2021–2032)
 Figure 35. China Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Artificial Heart Lung Machines Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Artificial Heart Lung Machines Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Artificial Heart Lung Machines Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Artificial Heart Lung Machines Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Artificial Heart Lung Machines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Artificial Heart Lung Machines by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Artificial Heart Lung Machines by Type (2021–2032)
 Figure 56. Global Artificial Heart Lung Machines Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Artificial Heart Lung Machines by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Artificial Heart Lung Machines by Application (2021–2032)
 Figure 59. Global Artificial Heart Lung Machines Price (USD/Unit) by Application (2021–2032)
 Figure 60. Artificial Heart Lung Machines Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS